Comparing Medtronic and Walgreens Boots Alliance for Superior Dividend Paying Stocks

Medtronic: Leading Innovation in Medical Technology

Medtronic has a remarkable history of raising dividends for 46 consecutive years, offering a 3.2% yield at recent prices. The company's product portfolio expansion, including recent FDA approvals, sets the stage for continued growth. Despite challenges faced during the pandemic, Medtronic's sales have shown a promising 7% increase over the past three years.

Walgreens Boots Alliance: Struggles in Diversification

Walgreens Boots Alliance faces hurdles in its diversification strategy, leading to a 48% dividend reduction in recent times. The company's partnership losses and impaired investments have impacted its financial performance, raising concerns about future profitability. With retail pharmacy margins under pressure and no clear growth strategy, Walgreens' long-term dividend outlook appears uncertain.